Study of pregabalin (Lyrica®) therapy in adolescent FM patients ages 12-16

This 15-week, randomized, double blind, parallel group, flexible dose trial of safety and effectiveness should soon be actively recruiting adolescent patients diagnosed with fibromyalgia.

Interested parties may e-mail the study sponsor – Pfizer, Inc.– to obtain contact information for a study near them. (A link is offered within the listing for this upcoming trial at

Pregabalin has been approved by the FDA as a drug that may be prescribed for symptoms of adult fibromyalgia patients.

1 Star2 Stars3 Stars4 Stars5 Stars (1 votes, average: 4.00 out of 5)

Leave a Reply